Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

TCS Group redomiciles to Russia

12/14/23 T

Sovcombank's IPO went over the top

12/14/23 SVCB

Fesco will create direct container communication between Tashkent and Moscow

12/14/23 FESH

Ozon will launch a platform to search for trucking companies

12/14/23 OZON

SPB Exchange plans to develop the derivatives market

12/14/23 SPBE

Genetico reported for 9 months 2023 by RAS

12/13/23 GECO

Aeroflot's passenger turnover in November increased by 38.3%

12/13/23 AFLT

Shareholders of European Eltech approved dividends and buyback

12/13/23 EELT

RusAgro argued with the co-owners of Agro-Belogorye

12/13/23 RAGR

JSFC Sistema reported for 9 months 2023 by IFRS

12/13/23 AFKS